Florida Medical Cannabis Hits 7.39B mg of THC in 2026

Florida's medical cannabis program is now moving more than a billion milligrams of THC every two weeks. Through April 30, 2026, the state's regulated patients have purchased 7.39 billion milligrams of THC and 2.49 million ounces of smokable flower — a pace that puts Florida's medical-only program ahead of most fully legalized adult-use markets in the country. The market has 758 active dispensaries, 924,820 registered patients, and a small group of vertically integrated operators that account for the majority of sales.

The contrast with Florida's stalled legalization story is the headline. While the medical program prints record after record, Smart & Safe Florida's 2026 adult-use ballot push collapsed in February when state officials disqualified hundreds of thousands of signatures, putting recreational cannabis off the November ballot for at least the second cycle in a row. Florida's medical cannabis market is now the most successful "medical-only" cannabis program in the United States — and it's getting bigger every week.

Table of Contents

• The Numbers Through April 30, 2026
• Two-Week Velocity Tells the Real Story
• Trulieve, MÜV, and Curaleaf: The MSO Stack
• 758 Dispensaries — and a Patient Base Near 1 Million
• Why Florida's Medical Program Is So Big
• The 2026 Ballot Failure: Adult-Use Dies Again
• What Comes Next for Florida's Market
• Bottom Line for Patients and Operators

The Numbers Through April 30, 2026

The Florida Office of Medical Marijuana Use's most recent weekly update — the data point that closed the books on April — captures a market still in growth mode roughly a decade into the program. Year to date through April 30, 2026:

• 7,389 million mg of THC (7.39 billion mg) sold across the program.
• 2,494,000 ounces of smokable marijuana sold to patients.
• 758 active dispensary locations statewide, up from roughly 700 at the start of the year.
• 924,820 registered patients — within striking distance of the 1 million-patient milestone, though weekly registrations have flattened.

To put 7.39 billion milligrams in context, the state's program crossed 5 billion mg of THC in late March, meaning Florida sold roughly 2.3 billion mg of THC in five weeks — the fastest sustained THC sell-through in the program's history. The program is on pace to clear 20 billion mg of THC for full-year 2026, which would represent an all-time record by a wide margin.

Two-Week Velocity Tells the Real Story

The most interesting number in the latest report isn't the cumulative total — it's the trailing two-week window, the window regulators use to track real-time demand:

• April 17 – April 30, 2026: 984.1 million mg of THC and 318,576.8 ounces of smokable flower.

That's nearly a billion milligrams of THC every two weeks — and roughly 320,000 ounces of flower, which works out to roughly 22,750 ounces per day, every day, across the state. Florida is on a velocity that translates to a weekly run-rate of about 490 million mg of THC and 160,000 ounces of flower.

For dispensary operators, this velocity is what really matters. Florida's program has moved past the "growth phase" rhythm of monthly records and into a sustained high-volume rhythm where small operational improvements — better inventory turns, faster fulfillment, more locations near patient density — convert directly into millions of dollars of incremental revenue per quarter.

Trulieve, MÜV, and Curaleaf: The MSO Stack

Florida's vertically integrated license structure rewards scale, and the latest two-week numbers show exactly how concentrated the market has become at the top:

| Operator | Two-Week THC (mg) | Two-Week Flower (oz) | Approx. Locations | | --- | --- | --- | --- | | Trulieve | 95.2 million | 47,608 | 169 | | MÜV (Verano) | 49.6 million | 15,345 | ~80 | | Curaleaf | 46.5 million | 14,635 | ~65 |

Trulieve is the dominant force in Florida's medical market — and has been since the program's earliest days. With 169 dispensary locations, Trulieve operates roughly 22% of all licensed dispensaries in the state, and it sold nearly twice as much THC as the next-largest operator over the most recent two-week reporting period. The company's home-state advantage in Florida is one of the most valuable single-state positions in U.S. cannabis.

MÜV (operated by Verano Holdings) and Curaleaf round out the top tier and have been steadily expanding their footprints. Below the top three, a long tail of regional operators including Sunnyside (Cresco), AYR Wellness, Sanctuary, and Surterra Wellness compete for the remaining patient share.

The takeaway for patients: where you live in Florida largely determines which operator you'll shop with, and price/quality varies meaningfully across operators. A patient near a Trulieve flagship gets very different selection than a patient in a market dominated by MÜV or AYR.

758 Dispensaries — and a Patient Base Near 1 Million

Florida's 758 active dispensary locations as of April 30 represent one of the densest medical-only retail networks in the country. For comparison, that's more storefronts than New York's adult-use market (~610) and significantly more than Massachusetts' total (~400).

The patient side of the ledger looks different. The state added patients aggressively from 2018 through 2024, but registration has flattened in 2025–2026, with weekly numbers oscillating in a narrow band around 925,000. The week-over-week change in the most recent report was a slight decline of 391 patients (from 925,211 to 924,820), suggesting the program is now in a steady-state rhythm where new patient onboarding roughly matches expirations and inactive cards.

This matters because it means Florida's growth in THC volume is not coming from new patients — it's coming from existing patients consuming more, switching to higher-THC products, and shifting toward concentrates and edibles where milligrams add up faster. Average mg per patient has been quietly climbing all year.

If you're just getting started in Florida, our step-by-step Florida medical card guide walks through the qualifying conditions, telehealth options, and the actual cost breakdown to get certified.

Why Florida's Medical Program Is So Big

Three structural features explain why Florida — a state that has twice rejected adult-use legalization — runs the largest medical-only cannabis market in the country.

1. The 2016 Amendment 2 framework is genuinely permissive. Florida's medical program covers more than 20 qualifying conditions including chronic pain, PTSD, anxiety, and any "debilitating medical condition of like kind or class," which physicians have interpreted broadly. The certification process is patient-friendly, with telehealth options widely available.

2. The 2.5-ounce-per-35-day cap is generous, with physician override. Most medical states use restrictive monthly purchase caps that throttle high-volume patients. Florida's 2.5-ounce/35-day cap — combined with physician-overrideable limits for inhalable products — effectively allows heavy users to operate as if there were no cap.

3. There's no statewide excise tax on medical cannabis. Florida charges medical patients only the standard sales tax, with no cannabis-specific excise. That keeps shelf prices roughly 20–30% below comparable adult-use markets, which in turn drives higher per-patient consumption.

The combination of broad qualifying conditions, generous purchase caps, and competitive pricing has produced a medical program that, in raw demand terms, behaves like a hybrid medical/adult-use market in everything but legal classification.

The 2026 Ballot Failure: Adult-Use Dies Again

The 7.39 billion mg headline lands against a backdrop of political setback. Smart & Safe Florida's 2026 adult-use ballot initiative — the second attempt after 2024's Amendment 3 narrowly missed Florida's 60% supermajority threshold — collapsed earlier this year when state election officials told local supervisors to invalidate roughly 200,000 signatures. By the February 1, 2026 deadline, only 613,206 valid signatures had been certified against the 880,062 required to qualify for the November 2026 ballot.

The Florida Phoenix and other state outlets have covered the legal back-and-forth in detail, but the takeaway is straightforward: Florida will not vote on adult-use cannabis in 2026. Smart & Safe has signaled it will continue collecting signatures with a future cycle in mind, but the next realistic shot at a statewide vote is 2028 — and even that assumes the campaign can survive ongoing legal challenges and meet the higher signature thresholds Florida regulators have moved toward.

For background, see our coverage of why Florida's 2024 ballot effort fell short and the 2026 ballot signature collapse.

For now, the practical implication for the industry is that Florida remains a medical-only state through at least 2028. That's actually a tailwind for the existing top-three MSOs: in adult-use states, vertically integrated incumbents typically lose share to lower-priced competitors as the market opens. Florida's MSOs get to keep their margin structure intact while consumption keeps climbing.

What Comes Next for Florida's Market

A few things to watch over the next two reporting cycles:

• Will Florida cross 1 million registered patients by year-end? It's the symbolic milestone, but the more interesting question is whether new patient registrations will reaccelerate or stay flat.
• Federal rescheduling implications. The DOJ's recent Schedule III order specifically carves out FDA-approved products and state-licensed medical cannabis activity. Florida operators are well-positioned to benefit from any 280E tax relief that flows through to state-licensed medical activity, although the IRS guidance is still developing.
• The DEA's June 29, 2026 hearing. Whatever comes out of that hearing on broader marijuana classification could affect how Florida's medical program is treated under federal banking, payment, and tax rules.
• Hemp-derived THC competition. Florida has not yet enacted its own state-level intoxicating hemp ban, even as the federal Farm Bill moves toward an end-of-year cutoff. If the federal ban takes effect on schedule, a chunk of demand currently flowing to gas stations and smoke shops could flow back into the licensed medical channel — a potential 2027 boost for Trulieve, MÜV, and Curaleaf.

Bottom Line for Patients and Operators

Florida's medical cannabis program is bigger than ever, more concentrated at the top than ever, and — barring a ballot reversal that doesn't appear to be coming — locked in as a medical-only market for the foreseeable future. For patients in Orlando dispensaries and across the rest of the state, the practical reality is steady access through one of the largest licensed dispensary networks in the country. For operators, Florida is one of the most profitable single-state plays in U.S. cannabis right now, and the velocity numbers suggest the runway is still expanding.

The adult-use story will keep getting written — but for 2026, the real Florida cannabis story is the medical program quietly setting records that very few legal markets in the country can match.

Looking for a licensed Florida dispensary you can actually trust? Find a dispensary near you on Budpedia — every shop in our directory is verified against state licensing data, and our Florida dispensaries hub breaks the network down by city for the 880,000 patients shopping it today.